Efficacy of ART to Interrupt HIV Transmission Networks
Efficacy of ART to Interrupt HIV Transmission Networks
批准号:
8658916
负责人:
SUSAN JANET LITTLE
金额:
$71.26万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-12 至 2019-02-28
关键词:
AIDS preventionAddressAffectAlcohol or Other Drugs useAnti-Retroviral AgentsCalibrationCommunitiesComputer SimulationConfidentiality of Patient InformationDataDemographic FactorsDisclosureDrug resistanceEffectivenessEpidemicEpidemiological FactorsEpidemiologyFutureGrowthHIVHIV InfectionsHIV diagnosisHeterosexualsHot SpotIncidenceIndividualInfectionInformation NetworksInterventionLinkMeasuresMethodsMolecular EpidemiologyNatureNetwork-basedParticipantPersonsPopulationPreventionPrevention strategyPreventive InterventionPrivacyProspective StudiesPublic Health Applications ResearchRandomizedReportingResearch InfrastructureResourcesRiskRisk EstimateSample SizeSampling BiasesSexually Transmitted DiseasesStructureTestingTimeTreatment Efficacyantiretroviral therapybasecohorteffective interventionefficacy testinginnovationinsightmen who have sex with mennovelpatient privacypopulation basedprospectivepublic health relevancerandomized trialreproductivesimulationstatisticstheoriestransmission processvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antiretroviral treatment (ART) markedly reduces the risk of HIV transmission between stable HIV discordant
heterosexual partners and increasing ART use can effect "population-level" reductions in HIV incidence.
Whether or not HIV prevention interventions, such as ART "Treatment as Prevention" (TasP) strategies can
significantly reduce epidemic growth rates remains a matter of considerable debate, though current
community-randomized TasP trials will require vast infrastructure and financial resources. Alternative, less
resource-prohibitive approaches are needed, that ideally would also provide real-time insight into HIV
transmission dynamics and be easily modified to address unique regional and epidemiological factors.
Prospective studies of prevention and treatment interventions that target epidemiologic "hot spots" of HIV
transmission may provide an opportunity to efficiently interrupt HIV transmission chains. Effective prevention
interventions are particularly relevant in populations of men who have sex with men (MSM) since their
incidence rates are disproportionately high compared to other risk groups. We propose to use molecular
epidemiology and computational modeling to estimate in real time the risk of onward HIV transmission in
newly HIV diagnosed persons. We have shown that by evaluating HIV sequences that are generated in 'real-
time' after a participant is identified from our San Diego Primary HIV infection Cohort (SD PIC), a partial
transmission network can be inferred rapidly and reliably, and this network can be leveraged to better measure
the efficacy of treatments and interventions, correlates of transmission risk, and estimate the size and features
of the San Diego HIV epidemic. The proposed study will also address concerns related to patient
confidentiality, specifically - unintended disclosure of HIV status or a putative transmission link. We will develop
sophisticated quantitative methods to preserve privacy prior to future consideration of potential public health
applications. Our primary hypothesis is that the efficacy of HIV prevention interventions, such as TasP (i.e.,
ART), can be measured within a well-characterized MSM epidemic, using network statistics to assess real time
changes in HIV transmission dynamics within the population. This proposal will address the following Specific
Aims: 1) To infer the San Diego HIV transmission network using molecular epidemiology and use agent-based
simulations to estimate features of the underlying infected population and efficacy of potential interventions, 2)
To assess the potential of molecular epidemiology and network statistics to measure the efficacy of ART as a
network-based prevention intervention, by comparing HIV transmission rates in persons who initiate early ART
compared to those who either delay or decline ART, and 3) To develop and deploy privacy preserving methods
for computing transmission network statistics. These same methods could be easily replicated in a prospective
fashion across diverse HIV epidemics and could help to prioritize interventions within the scope of available
resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
-
批准号:10653972
-
项目类别:
-
资助金额:$96.07万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Core-001 - COPE Core B
-
批准号:10602740
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
-
批准号:10460007
-
项目类别:
-
资助金额:$98.69万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Core-001 - COPE Core B
-
批准号:10459873
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10212958
-
项目类别:
-
资助金额:$73.77万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10405074
-
项目类别:
-
资助金额:$79.23万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10640251
-
项目类别:
-
资助金额:$77.35万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10082384
-
项目类别:
-
资助金额:$81.1万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Core B: Clinical and Anatomic Pathology Core
-
批准号:10223141
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2017
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Efficacy of ART to Interrupt HIV Transmission Networks
-
批准号:8848139
-
项目类别:
-
资助金额:$64.79万
-
财政年份:2014
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (PIRC)
-
批准号:9765135
-
项目类别:
-
资助金额:$339.42万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:9108834
-
项目类别:
-
资助金额:$144.35万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:9237672
-
项目类别:
-
资助金额:$17.83万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:8723059
-
项目类别:
-
资助金额:$160.12万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (PIRC)
-
批准号:10221460
-
项目类别:
-
资助金额:$338.03万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (PIRC)
-
批准号:9348986
-
项目类别:
-
资助金额:$331.19万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:8510795
-
项目类别:
-
资助金额:$143.09万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Determinants of HIV Transmission
-
批准号:8063769
-
项目类别:
-
资助金额:$211.39万
-
财政年份:2010
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Determinants of HIV Transmission
-
批准号:7917094
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2009
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Administrative Core
-
批准号:8375409
-
项目类别:
-
资助金额:$91.71万
-
财政年份:2008
-
负责人:SUSAN JANET LITTLE
-
依托单位:
海外基金